- Home
- ILPT vs PACB Comparison
ILPT vs PACB Comparison
Compare ILPT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILPT | PACB |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.0M | 462.8M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ILPT | PACB |
|---|---|---|
| Price | $8.66 | $1.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $7.05 | $1.67 |
| AVG Volume (30 Days) | 491.3K | ★ 5.5M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ 31.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $5.04 | $11.32 |
| Revenue Next Year | $2.18 | $12.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $4.50 | $1.09 |
| 52 Week High | $9.17 | $2.73 |
Technical Indicators
Market Signals| Indicator | ILPT | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 44.11 |
| Support Level | $8.47 | $1.18 |
| Resistance Level | $9.16 | $1.40 |
| Average True Range (ATR) | 0.35 | 0.11 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 53.85 | 4.21 |
Price Performance
Historical ComparisonAbout ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.